These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 31206841)

  • 21. Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery.
    Peppas NA
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1529-31. PubMed ID: 15350286
    [No Abstract]   [Full Text] [Related]  

  • 22. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?
    Duraisamy GS; Bhosale D; Lipenská I; Huvarova I; Růžek D; Windisch MP; Miller AD
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32906840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy.
    Liang L; Deng Y; Ao Z; Liao C; Tian J; Li C; Yu X
    J Drug Target; 2024 Jul; 32(6):606-623. PubMed ID: 38656224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomimetic and bioinspired strategies for oral drug delivery.
    Hu X; Yang G; Chen S; Luo S; Zhang J
    Biomater Sci; 2020 Feb; 8(4):1020-1044. PubMed ID: 31621709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
    Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
    Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging nanoparticle designs against bacterial infections.
    Zhou Z; Kai M; Wang S; Wang D; Peng Y; Yu Y; Gao W; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1881. PubMed ID: 36828801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine.
    Carvalho MR; Barata D; Teixeira LM; Giselbrecht S; Reis RL; Oliveira JM; Truckenmüller R; Habibovic P
    Sci Adv; 2019 May; 5(5):eaaw1317. PubMed ID: 31131324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomimetic Nanosponges for Treating Antibody-Mediated Autoimmune Diseases.
    Jiang Y; Fang RH; Zhang L
    Bioconjug Chem; 2018 Apr; 29(4):870-877. PubMed ID: 29357234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced efficacy of immersion vaccination in tilapia against columnaris disease by chitosan-coated "pathogen-like" mucoadhesive nanovaccines.
    Kitiyodom S; Yata T; Yostawornkul J; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N
    Fish Shellfish Immunol; 2019 Dec; 95():213-219. PubMed ID: 31585248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes.
    Vizirianakis IS
    Nanomedicine; 2011 Feb; 7(1):11-7. PubMed ID: 21094279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in biomimetic and nanostructured biohybrid materials.
    Ruiz-Hitzky E; Darder M; Aranda P; Ariga K
    Adv Mater; 2010 Jan; 22(3):323-36. PubMed ID: 20217713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetics: forecasting the future of science, engineering, and medicine.
    Hwang J; Jeong Y; Park JM; Lee KH; Hong JW; Choi J
    Int J Nanomedicine; 2015; 10():5701-13. PubMed ID: 26388692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomimetic particles as therapeutics.
    Meyer RA; Sunshine JC; Green JJ
    Trends Biotechnol; 2015 Sep; 33(9):514-524. PubMed ID: 26277289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomimetic theranostic nanoparticles for effective anticancer therapy and MRI imaging.
    Bigaj-Józefowska MJ; Coy E; Załęski K; Zalewski T; Grabowska M; Jaskot K; Perrigue P; Mrówczyński R; Grześkowiak BF
    J Photochem Photobiol B; 2023 Dec; 249():112813. PubMed ID: 37977004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomimetic Salmonella: A Next-Generation Therapeutic Vector?
    Felgner S; Kocijancic D; Pawar V; Weiss S
    Trends Microbiol; 2016 Nov; 24(11):850-852. PubMed ID: 27614692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.